Fair Trade with China Enforcement Act

Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis Legislative monitoring around China PNTR S. 2004 - A bill to amend the Tariff Act of 1930 relating to de minimis treatment under that Act. S. 1969 - A bill to amend the Tariff Act of 1930 to require reciprocity with respect to de minimis entries of articles, and for other purposes S. 1537 - Raising Tariffs on Imports from China Act of 2023 S. 153 - Fair Trade with China Enforcement Act H.R. 4148 - To amend the Tariff Act of 1930 relating to de minimis treatment under that Act H.R.6414 - Innovation and Development in Ecuador Act of 2023 S 913 - Innovation and Development in Ecuador Act of 2023 S.4110 - A bill to reauthorize the African Growth and Opportunity Act. HR 5744 - Energy Innovation and Carbon Dividend Act of 2023 S 3422 - Clean Competition Act HR 6622 - Clean Competition Act HR 6114 - Maximum Pressure Act H.R.7979 - End Chinas De Minimis Abuse Act H.R.7986 - Generalized System of Preferences Reform Act

Client expense: $2,620,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 8134, the Restoring America's Leadership in Innovation Act of 2024 (RALIA) H.R. 8132, Balancing Incentives Act of 2024 H.R. 7913, Generative AI Copyright Disclosure Act of 2024 H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis Legislative monitoring around China PNTR S. 2004 - A bill to amend the Tariff Act of 1930 relating to de minimis treatment under that Act. S. 1969 - A bill to amend the Tariff Act of 1930 to require reciprocity with respect to de minimis entries of articles, and for other purposes S. 1537 - Raising Tariffs on Imports from China Act of 2023 S. 153 - Fair Trade with China Enforcement Act H.R. 4148 - To amend the Tariff Act of 1930 relating to de minimis treatment under that Act H.R.6414 - Innovation and Development in Ecuador Act of 2023 S 913 - Innovation and Development in Ecuador Act of 2023 S.4110 - A bill to reauthorize the African Growth and Opportunity Act. HR 5744 - Energy Innovation and Carbon Dividend Act of 2023 S 3422 - Clean Competition Act HR 6622 - Clean Competition Act HR 6114 - Maximum Pressure Act

Client expense: $2,900,000 · Firm income: Not reported

H.R. 6684/S. 3569, Improving Efficiency to Increase Competition Act H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernation, IPEF, CBAM, and de minimis S. 2004 - A bill to amend the Tariff Act of 1930 relating to de minimis treatment under that Act. S. 1969 - A bill to amend the Tariff Act of 1930 to require reciprocity with respect to de minimis entries of articles, and for other purposes S. 1537 - Raising Tariffs on Imports from China Act of 2023 S. 153 - Fair Trade with China Enforcement Act H.R. 4148 - To amend the Tariff Act of 1930 relating to de minimis treatment under that Act

Client expense: $2,580,000 · Firm income: Not reported

H.R. 5475, Prohibiting Adversarial Patents Act of 2023 H.R. 6436, Stopping Pharmas Ripoffs and Drug Savings For All Act S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Client expense: Not reported · Firm income: Not reported

Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernation, IPEF, CBAM, and de minimis S. 2004 - A bill to amend the Tariff Act of 1930 relating to de minimis treatment under that Act. S. 1969 - A bill to amend the Tariff Act of 1930 to require reciprocity with respect to de minimis entries of articles, and for other purposes S. 1537 - Raising Tariffs on Imports from China Act of 2023 S. 153 - Fair Trade with China Enforcement Act H.R. 4148 - To amend the Tariff Act of 1930 relating to de minimis treatment under that Act

Client expense: $2,980,000 · Firm income: Not reported

S, 2934, the SHOP SAFE Act of 2023 H.R. 5475, Prohibiting Adversarial Patents Act of 2023 S. 2566, the American IP Defense and Enforcement Advancement Act S. 2140, Patent Eligibility Restoration Act of 2023 S. 2220/H.R. 4370, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S. 835/H.R. 1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R. 2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 H.R. 1398/S. 511, Protect Americas Innovation and Economic Security from CCP Act H.R. 5429/S. 2780, Medication Affordability and Patent Integrity Act Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Legislative monitoring of Open Skies Agreements Legislative monitoring of general trade issues including customs modernation, IPEF, CBAM, and de minimis S. 2004 - A bill to amend the Tariff Act of 1930 relating to de minimis treatment under that Act. S. 1969 - A bill to amend the Tariff Act of 1930 to require reciprocity with respect to de minimis entries of articles, and for other purposes S. 1537 - Raising Tariffs on Imports from China Act of 2023 S. 153 - Fair Trade with China Enforcement Act H.R. 4148 - To amend the Tariff Act of 1930 relating to de minimis treatment under that Act

Client expense: $3,100,000 · Firm income: Not reported

S. 2140, Patent Eligibility Restoration Act of 2023 H.R. 3858, No Free TRIPS Act H.R. 3535, Advancing Americas Interests Act H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S. 835/H.R. 1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R. 2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906, the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Client expense: $10,000 · Firm income: Not reported

H.R. 1707, the SMART Act S. 1128, Ensuring Access to Generic Medications Act S.835/H.R.1631, the Pro Codes Act S. 746/H.R. 1505, the No Stolen Trademarks Honored in America Act S. 574, Increasing Prescription Drug Competition Act S. 253/H.R. 791, the American Music Fairness Act of 2023 S. 153, the Fair Trade with China Enforcement Act S. 150, the Affordable Prescriptions for Patients Act S. 113 Pricing for the People Act S. 79/H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. S. 42, Prescription Preserve Access to Affordable Generics and Biosimilars Act H.R.2594 - To control the export to the People's Republic of China of certain technology and intellectual property important to the national interest of the United States, and for other purposes. H.R. 2070 - To provide for a limitation on availability of funds for Executive Office of the President, Intellectual Property Enforcement Coordinator for fiscal year 2024 H.R. 1016, the Stop Chinas IP Theft Act H.R. 906 , the REPAIR Act H.R. 576, the Copyright Clause Restoration Act of 2023 Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Modernization Issues related to the WTO TRIPs Waiver Request

Client expense: Not reported · Firm income: Not reported